Treatment with E2 has been shown to protect against obesity and alterations in glucose-insulin homeostasis in male mice fed high-fat diets [54], and to regulate leptin sensitivity to modulate feeding [55]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.